Shopping Cart
- Remove All
- Your shopping cart is currently empty
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | Inquiry | 1-2 weeks | |
50 mg | Inquiry | 1-2 weeks | |
100 mg | Inquiry | 1-2 weeks |
Description | Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medic |
Targets&IC50 | GT2a:0.08±0.02 nM (Ki), GT2b:0.15±0.06 nM (Ki), GT3a:0.90±0.2 nM (Ki), GT1a:0.01±0.01 nM (Ki), GT1b:0.01±<0.01 nM (Ki) |
Alias | MK-5172, MK5172, MK 5172, Grazoprevir |
Molecular Weight | 784.92 |
Formula | C38H52N6O10S |
Cas No. | 1350462-55-3 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: Soluble H2O: Insoluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.